Robert Paul
Chief Executive Officer presso Nine Square Therapeutics, Inc.
Profilo
Robert Paul is currently the Chief Executive Officer at Nine Square Therapeutics, Inc. He previously worked as the Chief Medical Officer at Alector, Inc. from 2016 to 2021 and as the Assistant Director-Group Medical at Genentech, Inc. from 2015 to 2016.
Dr. Paul holds a doctorate degree from Ludwig-Maximilians-Universität München.
Posizioni attive di Robert Paul
| Società | Posizione | Inizio |
|---|---|---|
Nine Square Therapeutics, Inc.
 Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Chief Executive Officer | 11/01/2022 |
Precedenti posizioni note di Robert Paul
| Società | Posizione | Fine |
|---|---|---|
| ALECTOR, INC. | Chief Tech/Sci/R&D Officer | 11/10/2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/10/2016 |
Formazione di Robert Paul
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALECTOR, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Robert Paul
